Found: 9
Select item for more details and to access through your institution.
Sequential Therapy for Hepatocellular Carcinoma after Failure of Atezolizumab plus Bevacizumab Combination Therapy.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Reply to the Letter "Comment on Regarding Manuscript 'Treatment of Intermediate Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies'".
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Comment on the Manuscript "Treatment of Intermediate-Stage Hepatocellular Carcinoma in Japan: Position of Curative Therapies".
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Hepatic Arterial Infusion Chemotherapy Combined with Radiation Therapy for Advanced Hepatocellular Carcinoma with Tumor Thrombosis of the Main Trunk or Bilobar of the Portal Vein.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 151, doi. 10.1159/000513706
- By:
- Publication type:
- Article
MRI Features for Predicting Microvascular Invasion of Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 94, doi. 10.1159/000513704
- By:
- Publication type:
- Article
Evolutions in the Management of Hepatocellular Carcinoma over Last 4 Decades: An Analysis from the 100 Most Influential Articles in the Field.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 137, doi. 10.1159/000513412
- By:
- Publication type:
- Article
Time-Varying mHAP-III Is the Most Accurate Predictor of Survival in Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 126, doi. 10.1159/000513404
- By:
- Publication type:
- Article
What Can Be Done to Solve the Unmet Clinical Need of Hepatocellular Carcinoma Patients following Lenvatinib Failure?
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 115, doi. 10.1159/000513355
- By:
- Publication type:
- Article
Clinical Outcomes with Multikinase Inhibitors after Progression on First-Line Atezolizumab plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma: A Multinational Multicenter Retrospective Study.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 2, p. 107, doi. 10.1159/000512781
- By:
- Publication type:
- Article